|
“Dream team” of researchers tackles leading cause of vision loss
July 27, 2022
-
Dr. Catherine Tsilfidis has assembled a world-class team to bring discoveries with game-changing potential to patients with retinal disease
|
|
$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness
September 15, 2021
-
A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness.
|
|
Biomanufacturing partnership boosts Canada’s life-saving treatment and vaccine capacity
September 13, 2021
-
As Canada seeks to rebuild its biomanufacturing sector and support made-in-Canada solutions to global health challenges, The Ottawa Hospital, the University of Alberta and BioCanRx have collaborated to create Canada’s first full-service, end-to-end b
|
|
Ottawa Hospital Research Institute and Faculty of Medicine support three translational research projects through Blueprint Excelerator
March 10, 2021
-
The Ottawa Hospital Research Institute (OHRI) and the Faculty of Medicine are providing up to $150,000 in in-kind support to help translate three laboratory research projects into clinical applications. The three projects will receive support from th
|
|
Gene therapy for deadly newborn lung disease shows promise in mice
October 26, 2020
-
One in a million babies are born with Surfactant Protein B deficiency, a genetic disorder in the lungs that will kill them before their first birthday. The only cure is a lung transplant.
|
|
Experimental stem cell therapy tested for rare lung disease
April 30, 2018
-
A Canadian-led research team has launched a clinical trial of an experimental stem cell therapy for pulmonary arterial hypertension. This rare and deadly disease occurs when the arteries that supply blood to the lungs become so damaged that blood can
|
|
Could stem cells repair the heart, fight infections, mend premature lungs, and heal the brain after stroke?
April 11, 2018
-
Ottawa researchers closer to finding out, thanks to $999,900 from the Stem Cell Network
Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks
|
